Understanding Epilepsy in Muscle-Eye-Brain Disease Patients
Researchers studied the characteristics of epilepsy in patients with Muscle-Eye-Brain disease (MEB), a rare genetic condition that affects muscle and brain development.
This hub covers epilepsy devices and neuromodulation like VNS, RNS, and DBS, which are treatments that can reduce seizures when meds aren’t enough. Plain-language research summaries plus real-life pros/cons.
Some are used more often in adults, but pediatric use depends on the device, the case, and specialist guidance.
Often gradually. Improvement can build over months as settings are optimized.
Sometimes medication can be reduced, but many people still use meds alongside a device.
Sometimes yes, with device-specific rules. Always check the exact device guidelines first.
Researchers studied the characteristics of epilepsy in patients with Muscle-Eye-Brain disease (MEB), a rare genetic condition that affects muscle and brain development.
Researchers studied genetic testing for epilepsy in families, focusing on patients who have epilepsy and at least one close relative with the condition.
Researchers studied a family in China affected by genetic epilepsy with febrile seizures plus (GEFS+), a condition that can cause seizures during fever and has a range of symptoms.
Researchers studied the potential risks of neurodevelopmental disorders (NDDs) in children whose fathers used valproate, a medication often prescribed for epilepsy, during the time they were producing sperm.
Researchers studied the potential risks of neurodevelopmental disorders (NDDs) in children whose fathers used a medication called valproate during the time they were producing sperm.
Researchers studied how brain activity patterns might predict whether children with drug-resistant focal epilepsy would benefit from vagus nerve stimulation (VNS), a treatment option for epilepsy.
This study focused on developing a set of common data elements (CDEs) specifically for children with epilepsy in Korea.
This study looked at the potential of certain microRNAs as biomarkers for pediatric epilepsy, which is a common neurological disorder in children.
This study looked at how doctors who treat epilepsy program vagus nerve stimulators (VNS), a device used to help control seizures.